VRS
IOVA icon

Virginia Retirement Systems’s Iovance Biotherapeutics IOVA Stock Holding History

Virginia Retirement Systems’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Sell
108,050
-5,700
-5% -$21.7K ﹤0.01% 993
2026
Q1 		$399K Buy
113,750
+31,500
+38% +$101K ﹤0.01% 806
2025
Q4 		$225K Sell
82,250
-50
-0.1% -$116 ﹤0.01% 899
2025
Q3 		$179K Buy
+82,300
New +$194K ﹤0.01% 908
2025
Q2 		– Sell
-31,000
Closed -$103K – 1012
2025
Q1 		$103K Buy
+31,000
New +$160K ﹤0.01% 999
2023
Q2 		– Sell
-11,200
Closed -$68.4K – 1035
2023
Q1 		$68.4K Sell
11,200
-6,900
-38% -$47.6K ﹤0.01% 1015
2022
Q4 		$116K Sell
18,100
-8,100
-31% -$63.2K ﹤0.01% 1091
2022
Q3 		$251K Buy
+26,200
New +$302K ﹤0.01% 996
2021
Q2 		– Sell
-7,900
Closed -$250K – 1081
2021
Q1 		$250K Sell
7,900
-1,700
-18% -$70.5K ﹤0.01% 1034
2020
Q4 		$445K Buy
9,600
+400
+4% +$15.9K ﹤0.01% 884
2020
Q3 		$303K Sell
9,200
-9,500
-51% -$291K ﹤0.01% 927
2020
Q2 		$513K Sell
18,700
-1,900
-9% -$62.5K 0.01% 786
2020
Q1 		$617K Buy
20,600
+300
+1% +$7.95K 0.01% 724
2019
Q4 		$562K Buy
+20,300
New +$462K 0.01% 898

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Virginia Retirement Systems's IOVA Position: Q2 2026 in Review

Virginia Retirement Systems reduced its Iovance Biotherapeutics (IOVA) stake by 5% in Q2 2026, selling an estimated $21.7K and leaving 108,050 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Virginia Retirement Systems first reported a position in IOVA in Q4 2019 and has held it in 14 quarters since. The position peaked at $617K in Q1 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Virginia Retirement Systems held 108,050 shares of Iovance Biotherapeutics worth $449K as of Q2 2026.
  • Virginia Retirement Systems sold 5,700 Iovance Biotherapeutics shares in Q2 2026, an estimated $21.7K.
  • Iovance Biotherapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #993 holding.
  • Virginia Retirement Systems first reported a position in Iovance Biotherapeutics in Q4 2019 and has held it in 14 quarters since.
  • Virginia Retirement Systems's Iovance Biotherapeutics position peaked at $617K in Q1 2020.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.